Velasco-Arnaiz, Eneritz
Batllori, Marta
Monsonís, Manuel
Valls, Anna
Ríos-Barnes, María
Simó-Nebot, Sílvia
Gamell, Anna
Fortuny, Clàudia
Tebruegge, Marc
Noguera-Julian, Antoni http://orcid.org/0000-0001-7485-0583
Funding for this research was provided by:
Instituto de Salud Carlos III (FI20/00237, CM18/00054)
Departament de Salut, Generalitat de Catalunya (SLT008/18/00193)
Article History
Received: 24 May 2022
Accepted: 15 November 2022
First Online: 19 November 2022
Competing interests
: Dr. Marc TEBRUEGGE has received QuantiFERON assays at reduced pricing or free of charge for TB diagnostics projects from the manufacturer (Cellestis/Qiagen) in the past, and has received support for conference attendance from Cepheid. The manufacturers had no influence on the study design, data collection, analysis or interpretation, writing of the manuscript or decision to submit the data for publication. The rest of authors have no conflicts of interest to disclose.